secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001000694-24-000003
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Novavax to cut ~12% of global workforce; expects $4-7M restructuring charge in Q1 2024
--------------------------------------------------------------------------------

- Board approved ~12% global workforce reduction (9% of FTEs; remainder contractors/consultants).
- One-time severance and benefit charge estimated at $4M to $7M, primarily in Q1 2024.
- Resulting workforce expected to be ~30% lower vs. end of Q1 2023.
- Full annual cost savings expected in 2025; ~85% of annual impact realized in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000100069424000003/0001000694-24-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000100069424000003/nvax-20240130.htm
  HTML page:      https://secwatch.observer/filing/0001000694-24-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer